Speaker Profile
Ph.D., CEO, Crystal Genetics, Inc.
Biography
Dr. Bahram G. Kermani is an expert in the fields of genomics, computational biology, signal processing, and machine learning. Prior to starting Crystal Genetics, he held various executive and technical positions at Guardant Health, Complete Genomics, Illumina, and Bell Labs (Lucent). Dr. Kermani completed his postdoctoral fellowship at Duke University Medical Center. He received his Ph.D. and M.S. in electrical engineering, and minoring in biomedical engineering from North Carolina State University; and received his B.S. in electronics engineering from Amirkabir University of Technology. Dr. Kermani has several publications in the areas of genomics, biomedical engineering, and electrical engineering, and holds in excess of 47 issued patents in the United States, European Union, and Japan.
Liquid Biopsy Showcase:
Crystal Genetics, Inc.
Crystal Genetics is a genetic testing company, with a primary focus on early detection of cancer using liquid biopsy. Leveraging the powers of single-cell analysis, whole genome sequencing and AI, we target population-level cancer screening applications --all of which demand ultra-high specificity.
Screening Applications For Early Detection Of Cancer
Early detection of cancer using liquid biopsy has recently been en vogue, due to its potential to drastically improve the survival rate of cancer patients, while being minimally invasive. We present a high-specificity detection framework as mandated by screening applications.
Session Abstract – PMWC 2020 Silicon Valley
The PMWC 2020 Liquid Biopsy Showcase will provide a 15-minute time slot for selected liquid biopsy companies to present their latest technologies to an audience of leading investors, potential clients, and partners. We will hear from companies that advance the development of screening tests for oncology, immunotherapy, and other areas, based on detection and identification of circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), circulating RNA, circulating microRNAs, or extracellular vesicle (exosomes).
